STS 47th Annual Meeting Features Latest Cardiothoracic Research

January 25, 2011 - San Diego - The STS 47th Annual Meeting, with more than 100 educational sessions featuring the latest information on new technologies and research in the field of cardiothoracic surgery, will be held Jan. 31-Feb. 2 in San Diego.

The STS Annual Meeting provides a forum for cardiothoracic surgeons, the specialists who surgically treat disorders of the heart, lungs, esophagus, and major blood vessels of the chest cavity, to interact with world-renowned experts on topics related to research, surgical techniques, patient management, ethical, and political issues. More than 2,000 members of the cardiothoracic surgical team from around the world are expected to be in attendance in San Diego, making this the pre-eminent educational event for cardiothoracic surgeons in 2011. Annual Meeting sessions will address a variety of hot topics that can have far-reaching implications for patients.

  • Endoscopic approaches to coronary artery bypass surgery hold the hope for shorter and smoother patient recovery. As these minimally-invasive techniques are perfected and taught to more surgeons, fewer patients may have to undergo coronary artery bypass operations.
  • In addition, a series of papers will present the latest findings related to aortic valve replacement as a catheter-based procedure, a technique that could spare severely-ill patients invasive operative procedures.
  • Important research on use of left ventricular assist devices (LVADs) will also be presented. This cutting-edge technique offers hope for patients with severe heart failure, who can be ‘bridged’ with LVADs and stents to buy time in anticipation of a transplant down the road.
  • Patients with severe disability due to chronic emboli in the pulmonary artery have few good medical therapy options. Seminal research from the University of California, San Diego based on an impressive 2,500 cases will detail how surgeons can, by accessing the pulmonary artery, remove the chronic thrombus or clot in the artery to improve blood flow to lower blood pressure in the pulmonary artery and right ventricle.
  • There will also be several papers on the comparative effectiveness of stents and heart surgery. These include an update of the SYNTAX trial and ASCERT study, the results of which should aid in the decision making process regarding the management of coronary artery disease.

For more information and a complete agenda, visit www.sts.org/annualmeeting. Media can also view updated meeting information as it occurs through the STS Meeting Bulletin.

Media contact: Sharon Porta (sporta [at] sts [dot] org) or Nancy Puckett (npuckett [at] sts [dot] org).


Founded in 1964, the Society of Thoracic Surgeons is a not-for-profit organization representing more than 6,000 surgeons, researchers and allied health care professionals worldwide who are dedicated to ensuring the best possible outcomes for surgeries of the heart, lung, and esophagus, as well as other surgical procedures within the chest. The mission of the Society is to enhance the ability of cardiothoracic surgeons to provide the highest quality patient care through education, research, and advocacy.

 

###

|||